glp 1 drugs with fewest side effects Weight-Loss Medication and How to Manage Them Part 1 of a 3-Part
Description
143 The trials recruited adult participants with T2DM and significantly reduced body weight and improved blood sugar control in these patients

10.3109/15622970802573246 [DOI] [PubMed] [Google Scholar] Porter W
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Under the law, compounders are not allowed to prepare "essentially a copy" of an existing FDA-approved drug, but there's an exception when that drug is in short supply

Ishy PL, Fagerlund B, Broberg BV, Bak N, Knop FK, Glenthj BY, et al
Japan GLP-1 Receptor Agonist Market Analysis The Japan GLP-1 receptor agonist market was valued at USD 1.39 billion in 2025, supported by country's strong culture of early diabetes diagnosis, widespread adoption of precision pharmacotherapy for metabolic disorders, and robust clinical research capabilities in peptide therapeutics

While dehydration itself is not typically reported as a direct side effect in clinical trials, the risk stems from the common gastrointestinal side effects that can lead to fluid loss
